脑血管疾病是影响中国中老年人群健康的主要病种之一，其高致死率与高致残率给家庭及社会带来了沉重的经济与照料负担。在此背景下，神经介入治疗作为一种微创诊疗手段，在医学影像引导下利用经皮导管技术，对中枢神经系统及相关解剖部位（头颈、脊柱脊髓）病变开展诊断与治疗。凭借创伤小、安全性高、疗效显著等核心优势，该疗法在脑血管疾病领域地位日益凸显。未来，在耗材技术革新、患者诊疗意识提升以及医疗可及性改善的多重驱动下，中国神经介入医疗耗材市场规模有望持续扩张，发展前景广阔。
Cerebrovascular diseases represent a primary health threat to the middle-aged and elderly population in China. The associated high rates of mortality and disability impose a profound economic and caregiving burden on both families and society. In this context, neurointerventional therapy has emerged as a pivotal minimally invasive modality. Guided by medical imaging and utilizing percutaneous catheterization techniques, it enables the diagnosis and treatment of lesions within the central nervous system and related anatomical regions, including the head, neck, spine, and spinal cord. Characterized by minimal trauma, superior safety, and significant efficacy, this therapy is gaining increasing prominence in cerebrovascular care. Driven by continuous innovation in medical consumables, rising patient awareness, and enhanced healthcare accessibility, China’s neurointerventional consumables market is poised for sustained expansion and exhibits robust developmental potential.
如果您对神经介入医用耗材市场有进一步的研究需求，请联系我们：
沙利文 毛先生
E-mail: fred.mao@frostchina.com
